avVaa World Health Care Products Inc.(BULLETIN BOARD:AVVW) ,a global biotechnology company offering therapeutic,natural skin and health care products,has announced that Dr.Mark Alden,avVaa VP of Research and board member,reports that an on-going eczema/psoriasis study for NEUROSKIN Forte at the University of Medicine and Dentistry of New Jersey (UMDNJ) was approximately 50% complete by mid-January.A well-qualified dermatology research team at the UMDNJ is conducting this study.
展开▼
